Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Katherine Mackey and Kathryn Vela.
Katherine Mackey
Connection Strength
6.831
Kathryn Vela
  1. Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021 Jun; 174(6):W54-W55.
    View in: PubMed
    Score: 0.942
  2. Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021 02; 174(2):W25-W29.
    View in: PubMed
    Score: 0.922
  3. Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021 01; 174(1):W17.
    View in: PubMed
    Score: 0.916
  4. Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 12 15; 173(12):167-168.
    View in: PubMed
    Score: 0.910
  5. Update Alert 4: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 11 03; 173(9):W147-W148.
    View in: PubMed
    Score: 0.904
  6. Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 10 06; 173(7):130-131.
    View in: PubMed
    Score: 0.900
  7. Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 09 01; 173(5):W87.
    View in: PubMed
    Score: 0.894
  8. Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 08 04; 173(3):W66.
    View in: PubMed
    Score: 0.222
  9. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review. Ann Intern Med. 2020 08 04; 173(3):195-203.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.